Click here to close now.

SYS-CON MEDIA Authors: Dana Gardner, Elizabeth White, Liz McMillan, AppDynamics Blog, Pat Romanski

News Feed Item

Pharmacy Automation: Technologies and Global Markets

NEW YORK, April 8, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmacy Automation: Technologies and Global Markets
http://www.reportlinker.com/p096626/Pharmacy-Automation-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmacies_and_Drug_Stores

REPORT HIGHLIGHTS

The global pharmacy automation market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual growth rate (CAGR) of 8.8% over the five-year period, 2013 to 2018

This report provides:


An overview of the global market for pharmacy automation.
Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
A market breakdown of inpatient pharmacy automation into acute-care settings and long-term care settings.
A market breakdown of outpatient pharmacy automation into fast-track clinical settings, hospital retail settings, pharmacy benefit management services, and retail pharmacy chains
Comprehensive profiles of leading companies in the industry.

STUDY GOALS AND OBJECTIVES

This BCC Research report, Pharmacy Automation: Technologies and Global Markets (IAS026D), provides a comprehensive analysis of the pharmacy automation market's current operations and equipment, current trends and detailed patent analysis. The study includes information regarding statistics for medication errors, costs associated with pharmacy activities, the pharmacist shortage and many other issues affecting the pharmacy automation market. Major pharmacy automation product segments include in-depth market and competitive analyses.

REASONS FOR DOING THE STUDY

Although pharmacy automation dates back to the 1970s with the introduction of pill-counting machines, the pharmacy automation market continues to advance and to deliver impressive technology and improve efficiency.

The increasing demand for accuracy, safety, industry standards and competency in the pharmacy environment by regulatory authorities, manufacturers, healthcare professionals and consumers has forced the growth of this market.New opportunities in various settings will continue to surface—from small, private, family-owned pharmacies to large hospital and mail-order service facilities. Many small, private pharmacies are still conducting operations through manual and semi-manual methods, particularly in regions outside of the United States. The opportunity to fully automate these pharmacies surfaces more often each year, and with a growing compliance with bar-coding standards and new tracking capabilities with radio-frequency identification (RFID) technology, this trend will continue to increase at a rapid rate. A large portion of inpatient facilities are already highly automated; however, there are advancements in technology and performance improvements every year, and these pharmacies will continue to seek out the most efficient system to upgrade. In order to remain competitive in the pharmaceutical dispensing business, organizations will be highly dependent on efficient automation systems. Therefore, upgrades are likely to be an ongoing process.

CONTRIBUTION OF THE STUDY AND FOR WHOM

The intended audience includes all the stakeholders of the pharmacy market: drug manufacturing companies, drug vendors, independent pharmacies, hospitals, retail pharmacy chains. This includes mostly manufacturers, retailers and super retailers, technology providers, and research and development (R&D) companies.With its broad scope and in-depth analyses, this study will prove to be a valuable resource to anyone involved with or interested in the operations of pharmacy and more specifically automating pharmacy processes.

This study will provide information on these areas:

Structure and current market size of the pharmacy automation market as outlined with forecasts through 2018.
Impact of chronic diseases, growing and aging populations.
Current product suppliers and some of their technologies.
An in-depth market evaluation of the U.S. pharmacy automation market.
A look at the pharmacy service industry and its value.
Markets for United States; Europe; and where available Asia Pacific, Latin America and the rest of world.
Technology patent trends relating to automating processes in the pharmacy environment.
Profiles for more than 20 companies in the industry with significant contributions and market shares.

Since the study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, purchases, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making and system implementation, upgrades and new developments.

SCOPE AND FORMAT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the global pharmacy automation market. The geographical scope is global with special emphasis on the United States/Canada and developed Europe, with supplemental data covering other geographical markets and trends. The report identifies pharmacy automation markets by inpatient and outpatient pharmacy settings, and by product type. Within the global pharmacy automation market, there are two general pharmacy settings, each with other subsettings:
Inpatient pharmacy automation.
Acute-care settings.
Long-term-care settings.
Outpatient pharmacy automation.
Outpatient/fast-track clinical settings.
Hospital retail settings.
Pharmacy benefit management services and other mail-order settings.
Retail pharmacy chains.
Each segment is further extrapolated to provide detailed information of current and emerging products, current market estimates and market forecasts, and competitive analyses.

METHODOLOGY AND INFORMATION SOURCES

The information for this BCC Research report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 60 key executives, product managers and clinical specialists involved in the pharmacy automation industry. Secondary methods included published literature in the area of pharmacy technology and services, investment reports, company literature and various pharmacy-related business journals.All market data pertains the global market at the manufacturers' level.

Data are expressed in current U.S. dollars. The base year of the report is 2013, with historical data provided for 2011 and 2012, and forecast data provided for 2018. Historical base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2013 base year.Although this study provides information on a variety of pharmacy automation equipment, it does not include a comprehensive list of products available. Many companies offer products to a variety of industry types, including, but not limited to, the following industries:
Appliance industry.
Aircraft industry.
Automotive industry.
Electrical and electronics industry.
Communications industry.
Food production industry.
Some systems not covered in this study include those that are primarily used in other industry types but are, however, designed to accommodate other settings, including the medical and pharmacy industries.
Chapter- 1: INTRODUCTION

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND FOR WHOM
SCOPE AND FORMAT
METHODOLOGY AND INFORMATION SOURCES
GLOSSARY OF PHARMACY-RELATED TERMS [1]
LIST OF COMMON ACRONYMS
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY 3

MAJOR GLOBAL PHARMACY AUTOMATION MARKETS
KEY TRENDS
LEADING MANUFACTURERS

Chapter- 3: INDUSTRY OVERVIEW

PHARMACY AUTOMATION INDUSTRY STRUCTURE
BACKGROUND, HISTORY AND GROWTH OF THE PHARMACY AUTOMATION MARKET

Chapter- 4: ISSUES AFFECTING THE MARKET

BAR CODING AND ELECTRONIC MEDICATION ADMINISTRATION
HEALTHCARE PERSONNEL TRENDS

Chapter- 5: INPATIENT PHARMACY AUTOMATION

OVERVIEW
IMPLEMENTING THE SYSTEMS
PRODUCT DESCRIPTIONS
INPATIENT AUTOMATION COST BY EQUIPMENT TYPE
MARKET SIZE AND GROWTH
COMPETITIVE STRUCTURE AND MARKET SHARE

Chapter- 6: OUTPATIENT PHARMACY AUTOMATION

OVERVIEW
MARKET SIZE AND GROWTH

Chapter- 7: GLOBAL PHARMACY AUTOMATION MARKET SUMMARY

GLOBAL MARKET BY SEGMENT
GLOBAL MARKET BY EQUIPMENT TYPE
GLOBAL MARKET SHARES BY SEGMENT
GLOBAL MARKET SHARES BY EQUIPMENT TYPE
GLOBAL MARKET BY GEOGRAPHIC REGION
INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE

Chapter- 8: TECHNOLOGY

OVERVIEW
CURRENT USES OF TECHNOLOGY
PATENT EVALUATION

Chapter- 9: COMPANY PROFILES

AESYNT INC.
AMERISOURCEBERGEN CORP.
BAXTER INTERNATIONAL INC.
CAPSA SOLUTIONS LLC
CAREFUSION CORP.
CERNER CORP.
EUCLID SPIRAL PAPER TUBE CORP.
HEALTH ROBOTICS, S.R.L.
INNOVATION ASSOCIATES
KIRBY LESTER LLC.
McKESSON CORP.
MEDICAL PACKAGING INC.
OMNICELL INC.
PARATA SYSTEMS LLC
SCRIPTPRO LLC
SWISSLOG AG
TALYST INC.
TCGRX

Chapter- 10: APPENDICES

APPENDIX I: LEADING EQUIPMENT MANUFACTURERS
APPENDIX II: OTHER RELATED COMPANIES
APPENDIX III: HOSPITALS, RETAIL PHARMACIES, AND OTHERS
APPENDIX IV: ASSOCIATIONS AND ORGANIZATIONS
APPENDIX V: STATE CONTROLLED SUBSTANCES SCHEDULING AUTHORITIES AND OTHER CONTACT INFORMATION

List of Tables

GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018
Table 1 : LIST OF ABBREVIATIONS USED IN MEDICAL PRESCRIPTIONS AND POSSIBLE CONFUSION MEANINGS
Table 2 : ELECTRONIC HEALTHCARE "MEANINGFUL USE" STAGES ESTABLISHED BY CMS
Table 3 : "MEANINGFUL USE" TIMELINE ESTABLISHED BY CMS
Table 4 : AVERAGE ANNUAL ADVERSE DRUG REACTIONS AND MEDICATION ADMINISTRATION ERRORS
Table 5 : WIDELY REPORTED TYPES OF MEDICATION ERRORS
Table 6 : BENEFITS OF PRESCRIPTION MONITORING PROGRAMS FOR MEDICAL BOARDS
Table 7 : STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS
Table 8 : HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: 1980-2010
Table 9 : HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012
Table 10 : PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005-2011
Table 11 : PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005-2011
Table 12 : ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030

Table 13 : GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
Table 14 : GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010
Table 15 : U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050
Table 16 : ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990-2020
Table 17 : GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010
Table 18 : AVERAGE YEARLY ADMISSIONS AND CURRENT RESIDENTS BY TYPE OF HEALTHCARE FACILITY IN THE U.S., 2012
Table 19 : TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
Table 20 : NURSING HOMES RESIDENTS BY SELECTED U.S. STATE, 2011
Table 21 : HOSPICE FACTS, 2011 VS. 2012
Table 22 : HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011
Table 23 : WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50, 2000
Table 24 : ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE BY SELECTED COUNTRY, 2013 ESTIMATES

Table 25 : TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
Table 26 : U.S. COMMUNITY HOSPITAL COMPARISONS BY PROFIT TYPE, 2012
Table 27 : EXAMPLES OF LEADING FOR-PROFIT U.S. HOSPITAL CHAINS, 2012
Table 28 : EXAMPLES OF LEADING U.S. LONG-TERM-CARE FACILITIES, 2013
Table 29 : U.S. STATE AND FEDERAL PRISON POPULATIONS BY SELECTED CHARACTERISTICS, 2012
Table 30 : COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN INPATIENT APPLICATIONS
Table 31 : SUMMARY OF INPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST
Table 32 : GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018

Table 33 : GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013
Table 34 : PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Table 35 : PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Table 36 : GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER REVENUES, ESTIMATED 2013
Table 37 : U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010
Table 38 : UNITED STATES: MEDICATION THERAPY AND NUMBER OF MEDICATIONS MENTIONED AT OFFICE VISITS, 2010*
Table 39 : DOCTORS' CONSULTATIONS BY COUNTRY, 2011*
Table 40 : EXAMPLES OF LEADING U.S. PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND OTHER MAIL-ORDER GROUPS' SALES ACTIVITY, 2012–2013
Table 41 : EXAMPLES OF LEADING U.S. RETAIL PHARMACY CHAINS' SALES ACTIVITY
Table 42 : U.S. RETAIL PHARMACY CHAINS: NUMBER OF LOCATIONS BY STATE, 2012–2013
Table 43 : EXAMPLE COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN OUTPATIENT APPLICATIONS
Table 44 : SUMMARY OF OUTPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST
Table 45 : GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018
Table 46 : GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013
Table 47 : PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Table 48 : PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Table 49 : GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER REVENUES, ESTIMATED 2013
Table 50 : GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018

Table 51 : GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018
Table 52 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, THROUGH 2018
Table 53 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, THROUGH 2018
Table 54 : GLOBAL PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013
Table 55 : INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE, 2012-2013
Table 56 : PHARMACY AUTOMATION EQUIPMENT PROVIDER PRODUCT LIST
Table 57 : NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013
Table 58 : PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END, 2013
Table 59 : AMERISOURCEBERGEN'S FINANCIAL SUMMARY, 2009-2013
Table 60 : BAXTER INTERNATIONAL'S FINANCIAL SUMMARY, 2009-2013
Table 61 : CAREFUSION'S FINANCIAL SUMMARY, 2009-2013
Table 62 : CERNER'S FINANCIAL SUMMARY, 2009-2013
Table 63 : MCKESSON'S FINANCIAL SUMMARY, 2009-2013
Table 64 : OMNICELL'S FINANCIAL SUMMARY, 2009-2013
Table 65 : SWISSLOG'S FINANCIAL SUMMARY, 2009-2013

List of Figures

GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018
Figure 1 : UNINTENDED OPIOID ANALGESIC OVERDOSE DEATHS, 1999 VS 2010
Figure 2 : TOTAL NUMBER OF STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS BY YEAR OF ENACTMENT
Figure 3 : HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: 1980 TO 2010
Figure 4 : HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012
Figure 5 : PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005–2011
Figure 6 : PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005 THROUGH 2011
Figure 7 : ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030
Figure 8 : GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND PROJECTED 2015
Figure 9 : GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010
Figure 10 : U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050
Figure 11 : ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990–2020
Figure 12 : GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010
Figure 13 : HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011
Figure 14 : ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS BY SELECTED COUNTRY, 2013 ESTIMATES

Figure 15 : GLOBAL INPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018
Figure 16 : GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018
Figure 17 : GLOBAL INPATIENT PHARMACY AUTOMATION MARKET SHARES BY END USER, ESTIMATED 2013
Figure 18 : GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013
Figure 19 : PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Figure 20 : PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Figure 21 : INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARES, ESTIMATED 2013
Figure 22 : U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010
Figure 23 : DRUG SALES BY SELECTED COUNTRY, 2013 ESTIMATE
Figure 24 : GROWTH IN TOTAL NUMBER OF PHARMACY LOCATIONS BY PHARMACY CHAIN
Figure 25 : DISTRIBUTION OF WALGREEN PHARMACIES IN THE U.S. BY STATE, FISCAL 2013

Figure 26 : DISTRIBUTION OF CVS PHARMACIES IN THE U.S. BY STATE, 2012
Figure 27 : DISTRIBUTION OF RITE AID PHARMACIES IN THE U.S. BY STATE, 2012-2013
Figure 28 : GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018
Figure 29 : GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018
Figure 30 : GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013
Figure 31 : PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Figure 32 : PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013
Figure 33 : GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET SHARES, ESTIMATED 2013
Figure 34 : GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018
Figure 35 : GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018
Figure 36 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2013
Figure 37 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2018
Figure 38 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2013
Figure 39 : GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2018

Figure 40 : GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013
Figure 41 : NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013
Figure 42 : PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END 2013
Figure 43 : AMERISOURCEBERGEN'S GROWTH SUMMARY, 2009-2013
Figure 44 : BAXTER INTERNATIONAL'S GROWTH SUMMARY, 2009-2013
Figure 45 : CAREFUSION'S GROWTH SUMMARY, 2009-2013
Figure 46 : CERNER'S GROWTH SUMMARY, 2009-2013
Figure 47 : MCKESSON'S GROWTH SUMMARY, 2009-2013
Figure 48 : OMNICELL'S GROWTH SUMMARY, 2009-2013
Figure 49 : SWISSLOG'S GROWTH SUMMARY, 2009-2013

To order this report: Pharmacy Automation: Technologies and Global Markets
http://www.reportlinker.com/p096626/Pharmacy-Automation-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmacies_and_Drug_Stores

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SAP is delivering break-through innovation combined with fantastic user experience powered by the market-leading in-memory technology, SAP HANA. In his General Session at 15th Cloud Expo, Thorsten Leiduck, VP ISVs & Digital Commerce, SAP, discussed how SAP and partners provide cloud and hybrid cloud solutions as well as real-time Big Data offerings that help companies of all sizes and industries run better. SAP launched an application challenge to award the most innovative SAP HANA and SAP HANA...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo in Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading in...
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete at launch. DevOps may be disruptive, but it is essential. The DevOps Summit at Cloud Expo – to be held June 3-5, 2015, at the Javits Center in New York City – will expand the DevOps community, enable a wide...
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at @ThingsExpo, Robin Raymond, Chief Architect...
There is no question that the cloud is where businesses want to host data. Until recently hypervisor virtualization was the most widely used method in cloud computing. Recently virtual containers have been gaining in popularity, and for good reason. In the debate between virtual machines and containers, the latter have been seen as the new kid on the block – and like other emerging technology have had some initial shortcomings. However, the container space has evolved drastically since coming on...
Cloud Expo, Inc. has announced today that Andi Mann returns to DevOps Summit 2015 as Conference Chair. The 4th International DevOps Summit will take place on June 9-11, 2015, at the Javits Center in New York City. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great team at ...
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In his session at Internet of @ThingsExpo, James Kirkland, Chief Ar...
The 17th International Cloud Expo has announced that its Call for Papers is open. 17th International Cloud Expo, to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, APM, APIs, Microservices, Security, Big Data, Internet of Things, DevOps and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding bu...
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo, June 9-11, 2015, at the Javits Center in New York City. Learn what is going on, contribute to the discussions, and ensure that your enter...
The security devil is always in the details of the attack: the ones you've endured, the ones you prepare yourself to fend off, and the ones that, you fear, will catch you completely unaware and defenseless. The Internet of Things (IoT) is nothing if not an endless proliferation of details. It's the vision of a world in which continuous Internet connectivity and addressability is embedded into a growing range of human artifacts, into the natural world, and even into our smartphones, appliances, a...
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
There is no doubt that Big Data is here and getting bigger every day. Building a Big Data infrastructure today is no easy task. There are an enormous number of choices for database engines and technologies. To make things even more challenging, requirements are getting more sophisticated, and the standard paradigm of supporting historical analytics queries is often just one facet of what is needed. As Big Data growth continues, organizations are demanding real-time access to data, allowing immed...
T-Mobile has been transforming the wireless industry with its “Uncarrier” initiatives. Today as T-Mobile’s IT organization works to transform itself in a like manner, technical foundations built over the last couple of years are now key to their drive for more Agile delivery practices. In his session at DevOps Summit, Martin Krienke, Sr Development Manager at T-Mobile, will discuss where they started their Continuous Delivery journey, where they are today, and where they are going in an effort ...
Enterprises are fast realizing the importance of integrating SaaS/Cloud applications, API and on-premises data and processes, to unleash hidden value. This webinar explores how managers can use a Microservice-centric approach to aggressively tackle the unexpected new integration challenges posed by proliferation of cloud, mobile, social and big data projects. Industry analyst and SOA expert Jason Bloomberg will strip away the hype from microservices, and clearly identify their advantages and d...
Container frameworks, such as Docker, provide a variety of benefits, including density of deployment across infrastructure, convenience for application developers to push updates with low operational hand-holding, and a fairly well-defined deployment workflow that can be orchestrated. Container frameworks also enable a DevOps approach to application development by cleanly separating concerns between operations and development teams. But running multi-container, multi-server apps with containers ...